ONDCP

Seattle will join San Francisco is expunging past petty pot possession convictions, the HHS secretary denies the reality of medical marijuana, the DOJ wants to toughen up a bill aimed at opioid makers and distributors, Colombia and the US reach an agreement on drug policy goals, and more.

Trump moves boldly backwards on drug policy with his FY 2019 budget request.

The proposed FY 2019 Trump budget features more drug and cutting the drug czar's office, a legal marijuana bill gets a hearing in New Hampshire, Oregon's governor declares a public health emergency over opioids, and more.

Good marijuana polling in Florida and New York, record marijuana sales in Colorado, the White House nominates a new drug czar, Purdue Pharma makes a big announcement, and more.

Safe injection sites are coming to San Francisco, House Democrats want a hearing on Sessions' backwards-looking marijuana policies, CBD bills pass in Indiana and Virginia, and more.

The president accuses Mexico and Central American countries of not doing enough to fight our drug war, a group of senators joins the call to save ONDCP, the German police association calls for marijuana legalization, and more.

Republican legislators are gumming things up in Maine and Virginia, a big coalition calls for preserving the drug czar's office, Amnesty International warns the Philippines, and more.

It's the time of year for marijuana to start popping up in state legislatures, Rhode Island's governor proposes expanding the state's medical marijuana system, Trump's wet-behind-the-ears deputy drug czar is stepping down, a new poll finds support for criminal justice reforms, and more.

Trump once again proposes radically slashing the drug czar's office, senators want answers on federal drug policy appointments (and the lack thereof), Vermont's governor will sign the legal pot bill this weekend, and more.

It was the best of times; it was the worst of times. Tens of thousands die of drug overdoses, hundreds of thousands get arrested for drugs, yet marijuana is seeing boom times. As we bid adieu to 2017, here are the year's drug policy highlights.